Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight study says

Obese or overweight patients who took Eli Lilly's retatrutide lost 58 pounds on average, the pharmaceutical company said in a mid-stage clinical trial.

from US Top News and Analysis https://ift.tt/tJrVdzH
https://ift.tt/FONzf7d